Related Experiment Video
Updated: Jun 1, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis
Ivan Wilmot1, David L S Morales, Jack F Price
1Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Insights
Mechanical circulatory support (MCS) offers a life-saving treatment for children with acute fulminant myocarditis. Survival rates are high, especially when viral infections are absent.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Cardiovascular Surgery
Background:
- Acute fulminant myocarditis poses a significant threat to children's lives.
- Mechanical circulatory support (MCS) shows promise in bridging pediatric patients to recovery or heart transplantation.
Purpose of the Study:
- To evaluate the effectiveness of MCS in pediatric myocarditis cases.
- To identify risk factors linked to adverse outcomes in children receiving MCS for myocarditis.
Main Methods:
- Retrospective analysis of 16 children treated with MCS (extracorporeal membrane oxygenation, ventricular assist devices, or both) between 2001 and 2009.
- Utilized polymerase chain reaction for viral pathogen detection and histologic analysis for myocardial inflammation assessment.
Main Results:
- Overall survival rate was 75% (12/16), with 7 patients recovering ventricular function and 5 undergoing heart transplantation.
- Significant improvement in left ventricular ejection fraction observed in patients bridged to recovery (20% to 62%, P = .0004).
- Viral presence was associated with increased mortality or need for transplantation (P = .011); absence of viral infection and inflammation correlated with recovery (P values .011 and .044).
Conclusions:
- MCS is a critical, life-saving intervention for children with acute fulminant and persistent myocarditis.
- The absence of viral infection is a key factor associated with favorable outcomes in pediatric myocarditis patients treated with MCS.
Background:
Acute fulminant myocarditis is a life-threatening disease in children. A limited number of reports suggest that mechanical circulatory support (MCS) may be used to successfully bridge children with acute fulminant myocarditis to recovery or transplantation. We evaluated the effectiveness of MCS in children with myocarditis and identified risk factors associated with adverse outcomes.
Methods And Results:
Between 2001 and 2009, 16 children were treated for myocarditis at our institution; each child received MCS provided by extracorporeal membrane oxygenation, ventricular assist device(s), or both. Of these patients, 75% (12/16) survived: 7 recovered ventricular function, and 5 underwent successful orthotopic heart transplantation. In patients who were bridged to recovery, mean left ventricular ejection fraction significantly improved from initiation to termination of MCS (20 ± 9.3% to 62 ± 5%; P = .0004). Viral pathogens were detected in 11 patients by polymerase chain reaction, and viral presence was associated with death or need for transplantation (P = .011). Upon histologic analysis, absence of viral infection and lack of myocardial inflammation were associated with recovery (P values .011 and .044, respectively).
Conclusions:
In children with acute fulminant and persistent myocarditis, MCS is a life-saving treatment strategy, particularly in the absence of viral infection.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis IV: Nursing Management